← Leaderboards
Frederick J Krambeck
Reactech, Inc.
$1,054,294
Attributed
$1,812,312
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $316.3K · FY2007–14$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,812,312 · 2
By mechanism
R01$1,516,036 · 1
R41$296,276 · 1
Top collaborators
- Kevin J Yarema5 shared
Others in their field
Top investigators on “Sugar”
- Gareth R Howell · Jackson Laboratory$21,454,210
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$21,056,995
- Marc A Hillmyer · University Of Minnesota-Twin Cities$20,000,000
- Karin Maria Hoffmeister · Versiti Blood Health, Inc.$17,883,249
- Timothy M Block · Callisto Pharmaceuticals, Inc.$17,508,047
- Carolyn R Bertozzi · University Of California San Francisco$17,328,883
Research focus
SugarAffectMalignant NeoplasmsStructurePolysaccharidesLinkGlycosylationMalignant - DescriptorProceduresResearch StudyProteinsPropertyCancer CellCellsBaseComputer SimulationCancer ModelAzidesBreast Cancer CellBiologicalAnimalsAnalogComplementCollaborations
Grant awards (7)
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs$297,635
R01 · FY2014 · CA
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs$288,413
R01 · FY2013 · CA
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs$306,834
R01 · FY2012 · CA
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs$306,824
R01 · FY2011 · CA
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs$316,330
R01 · FY2010 · CA
Mathematical model relating gene expression to glycoform structure$144,122
R41 · FY2008 · CA · contact PI
Mathematical model relating gene expression to glycoform structure$152,154
R41 · FY2007 · CA · contact PI